Back to AA Arax Advisory Partners

IPSCIPSC

5 quarters

Position history for AAArax Advisory Partners's holdings in Century Therapeutics, Inc.

Yes. Arax Advisory Partners holds 99 shares of IPSC (Century Therapeutics), worth $169, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Arax Advisory Partners has held IPSC since Q3 2025, across 5 quarterly 13F filings.

Current Value

$169

Current Shares

99

Total Value Change

+$120

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
99
0.0%
$1690.0%$1.71
0
2026-Q2
Unchanged
99
0.0%
$2430.0%$2.45
0
2026-Q1
Unchanged
99
0.0%
$2240.0%$2.26
0
2025-Q4
Unchanged
99
0.0%
$980.0%$1.00
0
2025-Q3
New
99
—
$490.0%$0.50
17

Optional analytics helps us improve. How it’s used